<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82402">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02040948</url>
  </required_header>
  <id_info>
    <org_study_id>2011/56</org_study_id>
    <nct_id>NCT02040948</nct_id>
  </id_info>
  <brief_title>Accuracy of Pulse Pressure Variation and of Pleth Variability Index to Predict the Response to a Fluid Challenge</brief_title>
  <acronym>Nexfin2</acronym>
  <official_title>Accuracy of Pulse Pressure Variation (Nexfin) and of Pleth Variability Index (Radical 7) to Predict the Response to a Fluid Challenge: Comparison With the Reference Method (Measurement of Stroke Volume by Esophageal Doppler)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the accuracy of Pleth Variability Index (Radical 7
      device) and of Pulse Pressure Variation (Nexfin device) with the Doppler measurement of
      stroke volume (esophageal Doppler) to detect the response to a fluid challenge.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Ability of Pleth Variability Index and of  Pulse Pressure Variation  to detect the response to a fluid challenge</measure>
    <time_frame>during the intraoperative period</time_frame>
    <safety_issue>No</safety_issue>
    <description>Three fluid challenges, 250 mL of a gelatine solution, are planned. Pleth Variability Index and Pulse Pressure Variation are compared to the measurement of stroke volume by Esophageal Doppler (the reference method)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inability to obtain Pleth Variability Index or Pulse Pressure Variation indices</measure>
    <time_frame>during the intraoperative period</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fluid Responsiveness</condition>
  <arm_group>
    <arm_group_label>Surgical patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nexfin (Pulse Pressure Variation)
Radical 7 (Pleth Variability Index)
CardioQ (stroke volume)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>- Nexfin (Pulse Pressure Variation) - Radical 7 (Pleth Variability Index) - CardioQ (stroke volume)</intervention_name>
    <arm_group_label>Surgical patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing major abdominal surgical procedures performed by laparotomy

          -  patients undergoing major urological surgical procedures performed by laparotomy

          -  patients undergoing major gynecological surgical procedures performed by laparotomy

          -  age ≥ 18 years

          -  signed informed consent

        Exclusion Criteria:

          -  pregnant women

          -  esophageal disease

          -  aortic valve disease

          -  allergy to gelatin

          -  BMI &gt; 35

          -  beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,

          -  presence of an arterio-venous shunt or of any other vascular disease on upper limb
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc Fischler, MD</last_name>
    <phone>46252442</phone>
    <phone_ext>00331</phone_ext>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Beaujon</name>
      <address>
        <city>Clichy</city>
        <state>Hauts de Seine</state>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Paugam-Burtz, MD</last_name>
      <phone>40875911</phone>
      <phone_ext>00331</phone_ext>
      <email>catherine.paugam@bjn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Julien Josserand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <state>Hauts de Seine</state>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Fischler, MD</last_name>
      <phone>46252442</phone>
      <phone_ext>00331</phone_ext>
      <email>m.fischler@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 17, 2014</lastchanged_date>
  <firstreceived_date>January 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
